Listed

Cumberland Pharmaceuticals Inc

CPIXNasdaqCIK 1087294HealthcareFiscal year ends Dec 31

Reports and events: 327 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cumberland Pharmaceuticals Inc, Reports and events
FiledFormWhat it isAccession number
2013-10-3118:45 ET8-K8.01 Other events0001087294-13-000013
2013-10-0717:31 ET8-K8.01 Other events0001445305-13-002363
2013-08-0917:13 ET8-K2.02 Results of operations0001087294-13-000011
2013-08-0917:07 ET10-QQuarterly reportPeriod 2013-06-300001087294-13-000009
2013-06-1416:50 ET8-K9.01 Financial statements and exhibits0001087294-13-000006
2013-06-0317:08 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001087294-13-000004
2013-05-0821:28 ET10-QQuarterly reportPeriod 2013-03-310001445305-13-001190
2013-05-0317:06 ET8-K2.02 Results of operations0001445305-13-001111
2013-04-1917:15 ET8-K5.07 Shareholder vote results0001445305-13-000850
2013-04-0816:08 ET8-K8.01 Other events0001445305-13-000792
2013-03-1416:31 ETDEF 14AProxy statementPeriod 2013-04-160001445305-13-000615
2013-03-1217:04 ET10-KAnnual reportPeriod 2012-12-310001445305-13-000573
2013-03-0417:53 ET8-K2.02 Results of operations0001445305-13-000444
2013-02-2618:12 ET8-K8.01 Other events0001445305-13-000313
2013-02-2117:07 ET8-K8.01 Other events0001445305-13-000280
2013-02-0116:30 ET8-K8.01 Other events0001445305-13-000138
2013-01-1116:02 ET8-K8.01 Other events0001193125-13-010725
2012-11-3016:58 ET8-K2.05 Exit or disposal costs0001299933-12-002670
2012-11-1617:03 ET8-K8.01 Other events0001299933-12-002591
2012-11-1308:56 ET8-K8.01 Other events0001299933-12-002539
2012-11-0909:04 ET8-K8.01 Other events0001299933-12-002530
2012-11-0217:00 ET10-QQuarterly reportPeriod 2012-09-300001193125-12-449319
2012-11-0116:57 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-12-002459
2012-09-1909:45 ET8-K8.01 Other events0001299933-12-002152
2012-08-0917:17 ET10-QQuarterly reportPeriod 2012-06-300001193125-12-347942
2012-08-0217:07 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-12-001843
2012-06-2916:32 ET8-K8.01 Other events0001299933-12-001580
2012-05-2417:29 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-12-247355
2012-05-1816:39 ET8-K8.01 Other events0001299933-12-001245
2012-05-0417:18 ET10-QQuarterly reportPeriod 2012-03-310001193125-12-212336
2012-05-0317:24 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001299933-12-001083
2012-04-2016:14 ET8-K5.07 Shareholder vote results0001299933-12-000915
2012-04-1117:09 ET8-K8.01 Other events0001299933-12-000830
2012-03-1206:11 ETDEF 14AProxy statementPeriod 2012-04-170001193125-12-107956
2012-03-0717:29 ET10-KAnnual reportPeriod 2011-12-310001193125-12-101478
2012-03-0116:40 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-12-000531
2011-11-2218:25 ET8-K1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001299933-11-003397
2011-11-0717:01 ET10-QQuarterly reportPeriod 2011-09-300000950123-11-096010
2011-11-0317:19 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-11-003222
2011-10-1817:43 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001299933-11-003050
2011-08-0817:15 ET10-QQuarterly reportPeriod 2011-06-300000950123-11-074496
2011-08-0510:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-11-002430
2011-06-2413:02 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0000950123-11-061495
2011-05-0917:19 ET10-QQuarterly reportPeriod 2011-03-310000950123-11-047522
2011-05-0516:17 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-11-001360
2011-04-2017:39 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001299933-11-001144
2011-04-0417:28 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001299933-11-001001
2011-03-1418:45 ETDEF 14AProxy statementPeriod 2011-04-190000950123-11-024911
2011-03-1117:19 ET10-KAnnual reportPeriod 2010-12-310000950123-11-024871
2011-03-0911:14 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001299933-11-000759

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 23:39 ET. Listed shows no prices and gives no investment advice.